Datafin

Data-driven stock analysis platform for global investors.

Sitemap
HomeScreenerValuationSector Analysis
Resources
LibraryDatafin GuideMetric MethodologyValuation MethodologiesFAQPricingWho Is Datafin?Communication
Legal
Privacy PolicyTerms of UseCookie PolicyKVKK NoticeRefund Policy
Data Sources

Financial data sourced from official regulatory filings and verified market data providers. Metrics calculated using GAAP/IFRS standards.

Disclaimer

The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

Investment decisions involve risk. Verify data independently and consult a licensed advisor when needed.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved.

Last updated: April 2026

ERF PEER ANALYSIS

Eurofins Scientific SE — metric-by-metric comparison with peers and the industry median

ERFEurofins Scientific SE

🇫🇷 France · PA · Healthcare · Diagnostics & Research

Value itDuel
PriceFinancialsPeers

Overall Profile & Returns

· Diagnostics & Research

Position Within Industry

0 = weak quartile, 100 = strong quartile
ValuationProfitabilityGrowthFinancial HealthDividend
ERFIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year
Split-adjusted
ERF+14.3%MEDP+75.8%RVTY+11.8%CRL+47.3%GH+234.3%LH+9.7%
Year-to-Date (YTD)
ERF+11.4%MEDP+0.6%RVTY+16.9%CRL+16.0%GH+65.3%LH+14.0%
1-Year
Split-adjusted
ERF+14.3%EL-24.3%SAN-5.5%
Year-to-Date (YTD)
ERF+11.4%EL-34.5%SAN-4.9%

Key Metric Comparison

P/E

Lower is better
ERF27.05MEDP35.55RVTY52.44CRL—GH—LH25.04Median 30.03

ROE

Higher is better
ERF10.7%MEDP77.3%RVTY3.3%CRL-6.0%GH—LH11.1%Median 6.4%

Net Margin

Higher is better
ERF6.5%MEDP17.2%RVTY8.3%CRL-4.6%GH-40.1%LH6.7%Median 6.7%

Revenue Growth

Higher is better
ERF5.0%MEDP24.2%RVTY4.8%CRL0.1%GH39.6%LH7.3%Median 9.1%

P/E

Lower is better
ERF27.05EL34.99SAN8.66Median 30.03

ROE

Higher is better
ERF10.7%EL5.8%SAN14.1%Median 6.4%

Net Margin

Higher is better
ERF6.5%EL8.1%SAN22.3%Median 6.7%

Revenue Growth

Higher is better
ERF5.0%EL7.5%SAN3.3%Median 9.1%

All Metrics

Valuation
MetricERFMEDPRVTYCRLGHLHInd. Median
P/E27.0535.5552.44——25.04●30.03
P/B3.6327.351.763.85-122.39●2.703.51
EV/EBITDA12.07●26.4019.5748.85—14.4620.91
P/S1.766.114.352.8120.521.67●4.27
Financial Health
MetricERFMEDPRVTYCRLGHLHInd. Median
Current Ratio1.090.851.721.364.68●1.731.87
Debt/Equity153.3%20.4%46.6%103.9%-941.4%●83.0%49.3%
NetDebt/EBITDA3.20-0.883.229.86-1.54●3.031.92
Profitability
MetricERFMEDPRVTYCRLGHLHInd. Median
Net Margin6.5%17.2%●8.3%-4.6%-40.1%6.7%6.7%
ROE10.7%77.3%●3.3%-6.0%—11.1%6.4%
ROA4.3%22.9%●2.0%-2.4%-26.6%5.1%3.3%
EBITDA Margin19.9%22.4%26.6%●7.2%-36.2%14.6%18.8%
Growth + Dividend
MetricERFMEDPRVTYCRLGHLHInd. Median
Rev. Growth5.0%24.2%4.8%0.1%39.6%●7.3%9.1%
NI Growth16.9%10.6%-22.4%——28.8%●12.4%
Div. Yield1.0%●—0.3%——1.0%0.8%
Payout23.2%—13.4%——25.5%23.2%
Valuation
MetricERFELSANInd. Median
P/E27.0534.998.66●30.03
P/B3.632.081.23●3.51
EV/EBITDA12.0714.049.57●20.91
P/S1.76●2.841.934.27
Financial Health
MetricERFELSANInd. Median
Current Ratio1.09●0.991.011.87
Debt/Equity153.3%37.0%27.5%●49.3%
NetDebt/EBITDA3.201.661.33●1.92
Profitability
MetricERFELSANInd. Median
Net Margin6.5%8.1%22.3%●6.7%
ROE10.7%5.8%14.1%●6.4%
ROA4.3%3.6%8.0%●3.3%
EBITDA Margin19.9%23.0%23.4%●18.8%
Growth + Dividend
MetricERFELSANInd. Median
Rev. Growth5.0%7.5%●3.3%9.1%
NI Growth16.9%-1.8%59.8%●12.4%
Div. Yield1.0%2.3%●0.0%0.8%
Payout23.2%0.0%0.0%23.2%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on ERF

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 6, 26. This content is for informational purposes only and is not investment advice.